Seller warrants good and clear title in goods subject to the sale (“Product”) and that the Product conforms at the time of shipment to a Certificate of Analysis, a Certificate of Compliance, or a Product Specification Sheet, if any such document exists, and other specifications signed by Seller (“Specifications”). Buyer acknowledges that information in Seller’s marketing materials, technical data sheets and other descriptive publications distributed or published on its websites may vary from time to time without notice. Buyer acknowledges that Seller has furnished to Buyer Safety Data Sheets, which include warnings together with safety and health information concerning the Product and/or the containers for such Product.

P1PC-011AquamixFactSheet2.indd Aquamix™ Dispersions & Emulsions Fact Sheet Ingredient Product % Activity Using 40 years of customization and technical expertise, Aquamix dispersions and emulsions from PolyOne® Chemists help latex formulators, adhesive manufacturers, specialty coatings producers, and polymer manufacturers shorten development cycles, streamline operations, and more effectively use resources. UV Stabilizer Dispersion Tinuvin® P Aquamix 150 50 UV absorber to prevent UV degradation Slab Dip Dispersions Clay Aquamix 186 65 Zinc Stearate Aquamix 394 25 Wax Amide Aquamix 1124 20 Calcium Stearate Aquamix 1172 50 Chemical Name / Comments 17 in 11 in 17.25 in 11.25 in CMYK P1PC-011AquamixFactSheet2.indd REMAY 72831-B Zig trim: 17.000" x 11.000" bleed: .125" Digital/IAM QC˛______ ______ Client˛_____ _____ Date ____/____/____ Proof No.4______ 25 50 100 25 50 100 25 2 2 50 100 25 2 2 50 100 Asset No. 72831-B Aquamix™ Dispersions & Emulsions Fact Sheet Ingredient Product % Activity Using 40 years of customization and technical expertise, Aquamix dispersions and emulsions from PolyOne® Chemists help latex formulators, adhesive manufacturers, specialty coatings producers, and polymer manufacturers shorten development cycles, streamline operations, and more effectively use resources.

Safety Data Sheets Technical Data Sheets Browse our library of product data sheets containing technical descriptions and details.

Avient’s Malmö, Sweden Site Earns ISCC PLUS Certification for Mevopur™ Healthcare Bio-based Polymer Solutions Mevopur™ Healthcare Bio-based Polymer Solutions manufactured in Malmö, Sweden, are now ISCC PLUS certified.

They can harm brand integrity, reduce consumer safety, and even increase the risk of product liability issues.   Safety shrink-wraps, stickers, and holograms are examples  Mevopur™ Bio-based Polymer Solutions

Mevopur™ Healthcare Functional Additives Mevopur™ Healthcare Functional Additives Mevopur™ Bio-based Polymer Solutions

Materials and their impact on patient safety Increased use of Quality by Design (QbD) processes means that more consideration needs to be given to materials used and their impact on patient safety. Fingerprinting and routine batch testing of the raw materials used in MEVOPUR and REMAFIN-EP help detect changes and implement countermeasures. Documentation supporting relevant product safety and compliance data is available to all customers.

P R O F I L E / S H E E T E X T R U D E R R A I L S A N D K I C K P L A T E S • Convert existing PVC profile and sheet rails and kick plates to polyolefin resin to meet Class A fire safety (ASTM E84) • Provide a system that meets healthy building certifications and approvals • Utilize a more sustainable flame retardant technology, removing brominated or halogenated flame retardants from the environment • Achieve non-compromising performance in aesthetics, impact, dimensional stability, CLTE, and E84 testing • Provided broad flame retardant platform, backed by extensive application and industry expertise, to meet global flammability standards • Has largest UL94 recognized Prospector membership with HB, V-0, V-1, V-2 and 5VA/5VB ratings, and broad glow wire performance products • Included in-house UL certified labs and manufacturing locations to perform UL94 material sampling and testing • Supported application development to meet fire safety standards, address current or emerging healthy building codes, smart home requirements, and LEED credits • Offered custom formulations in small lot quantities Cesa™ Flam Non-Halogen Flame Retardants KEY REQUIREMENTS WHY AVIENT?

Mevopur™ Healthcare Functional Additives Mevopur™ Bio-based Polymer Solutions Reduces the transfer of heat into the interiors of architectural structures by absorbing solar infrared energy into the fluoropolymer sheet

S&P 500 -150% -50% 50% 150% 250% 350% 450% 550% POL S&P 500 All time high of $43.34 July 1st, 2014 PolyOne Corporation Page 9 2006 2014 YTD 2015 “Where we were” “Where we are” Target 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 14.9% 12 – 16% Global Specialty Engineered Materials 1.1% 12.1% 12 – 16% Designed Structures & Solutions -- 7.6% 8 – 10% Performance Products & Solutions 5.5% 8.1% 9 – 12% Distribution 2.6% 6.2% 6 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 65% 65 – 75% 3) ROIC* 5.0% 10.6% 15% 4) Adjusted EPS Growth N/A 37% Double Digit Expansion Proof of Performance & 2015 Goals *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period PolyOne Corporation Page 10 32% Adjusted EPS CAGR from 2011 2015 EPS: $2.50 2011 EPS: $0.82 Continued Gross Margin Expansion Mergers & Acquisitions Spartech Accretion Incremental Share Buybacks Ongoing LSS Programs (50-100 bps/yr) Accelerated Innovation & Mix Improvement Several Levers to Drive Growth Mid Single Digit Revenue Growth PolyOne Corporation Page 11 Innovation Drives Earnings Growth *Percentage of Specialty Platform revenue from products introduced in last five years $20 $53 2006 2013 Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* 14% 31% 2006 2013 Specialty Platform Gross Margin % 20% 43% 2006 2013 Specialty Vitality Index Target ≥ 35% Vitality Products + 700 to 1000 bps PolyOne Corporation Page 12 Prototype Frame Opportunity Scale-up & Test Market Build Business Case Commercial Launch Phase 1 Phase 2 Phase 3 Phase 4 Phase 5 4 11 5 10 6 9 3 4 2 15 9 1 10 4 Breakthrough Platform Derivative A Rich Pipeline of Opportunity Number of Projects 25 14 19 17 18 93 Addressable Market ($ millions) TBD TBD $800 $450 $450 $1,700 PolyOne Corporation Page 13 Megatrends Aligned with Key End Markets Decreasing Dependence on Fossil Fuels Protecting the Environment Improving Health and Wellness Megatrend End Markets Globalizing and Localizing Health & Wellness Transportation Packaging Consumer PolyOne Corporation Page 14 60% 100% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2008 2014 Pension Funding** As of September 30, 2014 Debt Maturities & Pension Funding – 9/30/14 Net Debt / EBITDA* = 1.7x $48 $317 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Debt Maturities As of September 30, 2014 ($ millions) Coupon Rates: 7.500% 7.375% 5.250% ** includes US-qualified pension plans only *TTM 9/30/2014 PolyOne Corporation Page 15 Free Cash Flow and Strong Balance Sheet Fund Investment / Shareholder Return  Expanding our sales, marketing, and technical capabilities  Targets that expand our: • Specialty offerings • End market presence • Geographic footprint • Operating Margin  Synergy opportunities  Adjacent material solutions  Repurchased 1.5 million shares in Q3 2014  Repurchased 9.7 million shares since early 2013  10.3 million shares are available for repurchase under the current authorization Organic Growth Acquisitions Share Repurchases Dividends  Investing in operational and LSS initiatives (including synergy capture)  Manufacturing alignment $0.16 $0.20 $0.24 $0.32 $0.40 $0.10 $0.20 $0.30 $0.40 $0.50 2011 2012 2013 2014 2015 Annual Dividend PolyOne Corporation Page 16 PolyOne Core Values Innovation Collaboration Excellence PolyOne Corporation Page 17 The New PolyOne: A Specialty Growth Company Why Invest In PolyOne?  Strong past performance demonstrates that our strategy and execution are working  Megatrends and emerging opportunities align with our strengths  Innovation and services provide differentiation, incremental pricing power, and competitive advantage  Strong and proven management team driving growth and performance  Addressable market exceeds $40 billion 1 Schedule I Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except per share data) Below is a reconciliation of non-GAAP financial measures to the most directly comparable measures calculated and presented in accordance with U.S. Non GAAP Rec - 11 5 14.pdf Sidoti & Company non-GAAP Rec